Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Bailey

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Nature Materials|March 21, 2006
Liquid-crystalline semiconducting polymers with high charge-carrier mobilityIain McCulloch, Martin Heeney, Clare Bailey, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|January 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelRichard Gale, Mahmoud Husseiny Awad, Clare Bailey, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Ophthalmology|June 18, 2014
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edemaJosé Cunha-Vaz, Paul Ashton, Raymond Iezzi, et al.
Health Technology Assessment (Winchester, England)|December 17, 2016
An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectivenessAdnan Tufail, Venediktos V Kapetanakis, Sebastian Salas-Vega, et al.
Retina (Philadelphia, Pa.)|April 14, 2017
VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINEDCecilia S Lee, Alisa J Kim, Douglas Baughman, et al.
Ophthalmology. Retina|May 4, 2019
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular DegenerationUsha Chakravarthy, Clare Bailey, David Brown, et al.
Ophthalmology|June 26, 2012
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Nature Materials|March 21, 2006
Liquid-crystalline semiconducting polymers with high charge-carrier mobilityIain McCulloch, Martin Heeney, Clare Bailey, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|January 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelRichard Gale, Mahmoud Husseiny Awad, Clare Bailey, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Ophthalmology|June 18, 2014
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edemaJosé Cunha-Vaz, Paul Ashton, Raymond Iezzi, et al.
Health Technology Assessment (Winchester, England)|December 17, 2016
An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectivenessAdnan Tufail, Venediktos V Kapetanakis, Sebastian Salas-Vega, et al.
Retina (Philadelphia, Pa.)|April 14, 2017
VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINEDCecilia S Lee, Alisa J Kim, Douglas Baughman, et al.
Ophthalmology. Retina|May 4, 2019
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular DegenerationUsha Chakravarthy, Clare Bailey, David Brown, et al.
Ophthalmology|June 26, 2012
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Pageof 10